Changing HER2-status of the primary gastric tumor after neoadjuvant trastuzumab-based therapy. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results